Rezultati pretrage - Arlene A. Forastiere

Detaljiziraj rezultate
  1. 1
    Controversies in Treatment Deintensification of Human Papillomavirus–Associated Oropharyngeal Carcinomas: Should We, How Should We, and for Whom?

    Controversies in Treatment Deintensification of Human Papillomavirus–Associated Oropharyngeal Carcinomas: Should We, How Should We, and for Whom? od Harry Quon, Arlene A. Forastiere

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Carta
    Spremi u popis
    Spremljeno u:
  2. 2
    Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neck

    Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neck od Athanassios Argiris, Yi Li, Arlene A. Forastiere

    Izdano 2004
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes

    Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes od Arlene A. Forastiere, Randal S. Weber, Andy Trotti

    Izdano 2015
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  4. 4
    HPV-associated head and neck cancer: a virus-related cancer epidemic

    HPV-associated head and neck cancer: a virus-related cancer epidemic od Shanthi Marur, Gypsyamber D’Souza, William H. Westra, Arlene A. Forastiere

    Izdano 2010
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  5. 5
    Head and Neck Cancer: Recent Advances and New Standards of Care

    Head and Neck Cancer: Recent Advances and New Standards of Care od Arlene A. Forastiere, Andy Trotti, David G. Pfister, Jennifer R. Grandis

    Izdano 2006
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Outcome of Elderly Patients With Recurrent or Metastatic Head and Neck Cancer Treated With Cisplatin-Based Chemotherapy

    Outcome of Elderly Patients With Recurrent or Metastatic Head and Neck Cancer Treated With Cisplatin-Based Chemotherapy od Athanassios Argiris, Yi Li, Barbara A. Murphy, Corey J. Langer, Arlene A. Forastiere

    Izdano 2004
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Phase III Study of Radiation Therapy With or Without Cis-Platinum in Patients With Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of the Eastern Cooperative Oncology Group (E2382)

    Phase III Study of Radiation Therapy With or Without Cis-Platinum in Patients With Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of... od Harry Quon, Traci Leong, Robert E. Haselow, Bruce Leipzig, Jay S. Cooper, Arlene A. Forastiere

    Izdano 2010
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck

    A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck od Athanassios Argiris, Musie Ghebremichael, Barbara Burtness, Rita Axelrod, Ronald C. DeConti, Arlene A. Forastiere

    Izdano 2011
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region

    Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region od Tsung‐Teh Wu, Toshiaki Watanabe, Richard F. Heitmiller, Marianna Zahurak, Arlene A. Forastiere, Stanley R. Hamilton

    Izdano 1998
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma

    Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma od Mark B. Orringer, Arlene A. Forastiere, Claudia Perez-Tamayo, Susan G. Urba, Bonnie J. Takasugi, Judith Bromberg

    Izdano 1990
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  11. 11
    Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials

    Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials od Athanassios Argiris, S. Li, Musie Ghebremichael, Ann Marie Egloff, Ling Wang, Arlene A. Forastiere, Barbara Burtness, Ranee Mehra

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

    Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis od Mitchell Machtay, Jennifer Moughan, A. Trotti, Adam S. Garden, Randal S. Weber, Jay S. Cooper, Arlene A. Forastiere, K. Kian Ang

    Izdano 2008
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

    Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial od Athanassios Argiris, Musie Ghebremichael, Jill Gilbert, Ju-Whei Lee, Kamakshi Sachidanandam, Jill Kolesar, Barbara Burtness, Arlene A. Forastiere

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy

    Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy od Antonio Jimeno, P. Kulesza, Jenna Wheelhouse, Andrew M. Chan, X Zhang, E Kincaid, Allen Chen, Douglas P. Clark, Arlene A. Forastiere, Manuel Hidalgo

    Izdano 2007
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  15. 15
    Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients

    Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients od Amitabh Chak, Marcia I. Canto, Gregory S. Cooper, Gerard Isenberg, Joseph Willis, Nathan Levitan, Julie Clayman, Arlene A. Forastiere, Elisabeth I. Heath, Michael Sivak

    Izdano 2000
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    Association between Cigarette Smoking and Mutation of the p53 Gene in Squamous-Cell Carcinoma of the Head and Neck

    Association between Cigarette Smoking and Mutation of the p53 Gene in Squamous-Cell Carcinoma of the Head and Neck od Joseph Brennan, Jay O. Boyle, Wayne M. Koch, Steven N. Goodman, Ralph H. Hruban, Yolanda Eby, Marion Couch, Arlene A. Forastiere, David Sidransky

    Izdano 1995
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-14)

    Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-... od Adam S. Garden, Jonathan Harris, Andy Trotti, Christopher U. Jones, Luis A. Carrascosa, Jonathan D. Cheng, Sharon Spencer, Arlene A. Forastiere, Randal S. Weber, K. Kian Ang

    Izdano 2008
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    Phase II Trial of Chemoradiation for Organ Preservation in Resectable Stage III or IV Squamous Cell Carcinomas of the Larynx or Oropharynx: Results of Eastern Cooperative Oncology Group Study E2399

    Phase II Trial of Chemoradiation for Organ Preservation in Resectable Stage III or IV Squamous Cell Carcinomas of the Larynx or Oropharynx: Results of Eastern Cooperative Oncology... od Anthony J. Cmelak, Sigui Li, Meredith A. Goldwasser, Barbara A. Murphy, Michael W. Cannon, Harlan Pinto, David I. Rosenthal, Maura L. Gillison, Arlene A. Forastiere

    Izdano 2007
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  19. 19
    Hypopharyngeal Dose Is Associated With Severe Late Toxicity in Locally Advanced Head-and-Neck Cancer: An RTOG Analysis

    Hypopharyngeal Dose Is Associated With Severe Late Toxicity in Locally Advanced Head-and-Neck Cancer: An RTOG Analysis od Mitchell Machtay, Jennifer Moughan, Andrew Farach, Elizabeth Martin-O'Meara, James M. Galvin, Adam S. Garden, Randal S. Weber, Jay S. Cooper, Arlene A. Forastiere, K. Kian Ang

    Izdano 2012
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  20. 20
    Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14

    Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14 od K. Kian Ang, Jonathan Harris, Adam S. Garden, Andy Trotti, Christopher U. Jones, Luis A. Carrascosa, Jonathan D. Cheng, Sharon Spencer, Arlene A. Forastiere, Randal S. Weber

    Izdano 2005
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: